World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard/Overview (2022), https://covid19.who.int/
N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020)
N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020)
J.J. Zhang, X. Dong, Y.Y. Cao, Y.D. Yuan, Y.B. Yang, Y.Q. Yan et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy 75, 1730–41. (2020)
C. Wang, P.W. Horby, F.G. Hayden, G.F. Gao, A novel coronavirus outbreak of global health concern. Lancet 395, 470–473 (2020)
National Institutes of Health. Home. COVID-19 Treatment Guidelines/Therapies. https://www.covid19treatmentguidelines.nih.gov/
V. Bansal, K.S. Mahapure, A. Bhurwal, I. Gupta, S. Hassanain, J. Makadia, N. Madas, P. Armaly, R. Singh, I. Mehra, J.C. O’Horo, R. Kashyap, Mortality benefit of remdesivir in COVID-19: a systematic review and meta-analysis. Front. Med. 27(7), 606429 (2021). https://doi.org/10.3389/fmed.2020.606429
RECOVERY Collaborative Group, P. Horby, W.S. Lim, J.R. Emberson, M. Mafham, J.L. Bell, L. Linsell, N. Staplin, C. Brightling, A. Ustianowski, E. Elmahi, B. Prudon, C. Green, T. Felton, D. Chadwick, K. Rege, C. Fegan, L.C. Chappell, S.N. Faust, T. Jaki, K. Jeffery, A. Montgomery, K. Rowan, E. Juszczak, J.K. Baillie, R. Haynes, M.J. Landray, Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384(8), 693–704 (2021). https://doi.org/10.1056/NEJMoa2021436
M. Mazzitelli, E. Arrighi, F. Serapide, M.C. Pelle, B. Tassone, R. Lionello, G. Marrazzo, D. Laganà, F.S. Costanzo, G. Matera, E.M. Trecarichi, C. Torti, Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia. J. Med Virol. 93(1), 32–34 (2021). https://doi.org/10.1002/jmv.26016
Article CAS PubMed Google Scholar
A. De Vito, L. Saderi, V. Fiore, N. Geremia, E. Princic, C. Fanelli, A.A. Muredda, C.P. Napodano, G. Moi, I. Maida, A.G. Fois, G. Sotgiu, G. Madeddu, S. Babudieri, Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients. Panminerva Med. (2022), https://doi.org/10.23736/S0031-0808.22.04572-4
Food and Drug Administration. Home. Emergency preparedness and response. Counterterrorism and emerging threats. Coronavirus disease 2019 (COVID-19)/Emergency Use Authorizations (EUAs)/Drugs and Non-Vaccine Biological Products. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#coviddrugs
S.F. Mousavi, M. Ebrahimi, S.A.A. Moghaddam, N. Moafi, M. Jafari, A. Tavakolian, M. Heidary, Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study. Vacunas (2022), https://doi.org/10.1016/j.vacun.2022.08.002
L. Hu, Y. Xu, L. Wu, J. Feng, L. Zhang, Y. Tang, X. Zhao, R. Mai, L. Chen, L. Mei, Y. Tan, Y. Du, Y. Zhen, W. Su, T. Peng, The E484K substitution in a SARS-CoV-2 spike protein subunit vaccine resulted in limited cross-reactive neutralizing antibody responses in mice. Viruses 14(5), 854 (2022). https://doi.org/10.3390/v14050854
Article CAS PubMed PubMed Central Google Scholar
A. Kuzmina, S. Wattad, S. Engel, E. Rosenberg, R. Taube, Functional analysis of spike from SARS-CoV-2 variants reveals the role of distinct mutations in neutralization potential and viral infectivity. Viruses 14(4), 803 (2022). https://doi.org/10.3390/v14040803
Article CAS PubMed PubMed Central Google Scholar
S. Sun, J. Wu, R. Chen, M. Levitt, SARS-CoV-2 Omicron variant: viral spread dynamics, disease burden, and vaccine effectiveness. Curr. Med. 1(1), 14 (2022). https://doi.org/10.1007/s44194-022-00014-x
P.J. Macdonald, J.M. Schaub, Q. Ruan, C.L. Williams, J.C. Prostko, S.Y. Tetin, Affinity of anti-spike antibodies to three major SARS-CoV-2 variants in recipients of three major vaccines. Commun. Med. 2, 109 (2022). https://doi.org/10.1038/s43856-022-00174-9
Article PubMed PubMed Central Google Scholar
J. Berenguer, A.M. Borobia, P. Ryan, J. Rodríguez-Baño, J.M. Bellón, I. Jarrín, J. Carratalà, J. Pachón, A.J. Carcas, M. Yllescas, J.R. Arribas, COVID-19@Spain and COVID@HULP Study Groups. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. Thorax 76(9), 920–929 (2021). https://doi.org/10.1136/thoraxjnl-2020-216001
T. Meister, H. Pisarev, R. Kolde, R. Kalda, K. Suija, L. Milani, L. Karo-Astover, M. Piirsoo, A. Uusküla, Clinical characteristics and risk factors for COVID-19 infection and disease severity: a nationwide observational study in Estonia. PLoS ONE 17(6), e0270192 (2022). https://doi.org/10.1371/journal.pone.0270192
Article CAS PubMed PubMed Central Google Scholar
S. Karapetyan, A. Schneider, K. Linde, E. Donnachie, A. Hapfelmeier, SARS-CoV-2 infection and cardiovascular or pulmonary complications in ambulatory care: a risk assessment based on routine data. PLoS ONE 16(10), e0258914 (2021). https://doi.org/10.1371/journal.pone.0258914
Article CAS PubMed PubMed Central Google Scholar
M. Sadat Larijani, F. Ashrafian, F. Bagheri Amiri, M. Banifazl, A. Bavand, A. Karami, F. Asgari Shokooh, A. Ramezani, Characterization of long COVID-19 manifestations and its associated factors: a prospective cohort study from Iran. Micro. Pathog. 169, 105618 (2022). https://doi.org/10.1016/j.micpath.2022.105618
A. Zittermann, S. Pilz, H. Hoffmann, W. März, Vitamin D and airway infections: a European perspective. Eur. J. Med Res. 21, 14 (2016). https://doi.org/10.1186/s40001-016-0208-y
Article CAS PubMed PubMed Central Google Scholar
G. Schwalfenberg, Vitamin D for influenza. Can. Fam. Physician 61(6), 507 (2015)
PubMed PubMed Central Google Scholar
P.C. Ilie, S. Stefanescu, L. Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin. Exp. Res. 32(7), 1195–1198 (2020). https://doi.org/10.1007/s40520-020-01570-8
Article PubMed PubMed Central Google Scholar
D.M. McCartney, D.G. Byrne, Optimization of vitamin D status for enhanced immuno-protection against COVID-19. Ir. Med J. 113(4), 58 (2020)
W.B. Grant, H. Lahore, S.L. McDonnell, C.A. Baggerly, C.B. French, J.L. Aliano, H.P. Bhattoa, Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 Infections and Deaths. Nutrients 12(4), E988 (2020). https://doi.org/10.3390/nu12040988
Article CAS PubMed Google Scholar
N. Hutchings, V. Babalyan, S. Baghdasaryan, M. Qefoyan, N. Sargsyants, E. Aghajanova, A. Martirosyan, R. Harutyunyan, O. Lesnyak, A.M. Formenti, A. Giustina, J.P. Bilezikian, Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D. Endocrine 71(2), 267–269 (2021). https://doi.org/10.1007/s12020-020-02597-7
Article CAS PubMed PubMed Central Google Scholar
V. Baktash, T. Hosack, N. Patel, S. Shah, P. Kandiah, K. Van den Abbeele, A.K.J. Mandal, C.G. Missouris, Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad. Med J. 97(1149), 442–447 (2021). https://doi.org/10.1136/postgradmedj-2020-138712
F. Yasari, M. Akbarian, A. Abedini, M. Vasheghani, The role of electrolyte imbalances in predicting the severity of COVID-19 in the hospitalized patients: a cross-sectional study. Sci. Rep. 30 (12), 14732 (2022). https://doi.org/10.1038/s41598-022-19264-8
M. Pereira, A. Dantas Damascena, L.M. Galvão Azevedo, T. de Almeida Oliveira, J. da Mota Santana, Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 4, 1–9 (2020). https://doi.org/10.1080/10408398.2020.1841090
C. Annweiler, M. Beaudenon, R. Simon, M. Guenet, M. Otekpo, T. Célarier, J. Gautier; GERIA-COVID study group, Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID study. J. Steroid Biochem Mol. Biol. 213, 105958 (2021). https://doi.org/10.1016/j.jsbmb.2021.105958
Article CAS PubMed PubMed Central Google Scholar
V. Fiore, A. De Vito, P. Bagella, E. Princic, A.A. Mariani, L. Denti, A.G. Fois, G. Madeddu, S. Babudieri, I. Maida, Effectiveness of vitamin D supplements among patients hospitalized for COVID-19: results from a Monocentric Matched-Cohort Study. Healthcare. 10(5), 956 (2022). https://doi.org/10.3390/healthcare10050956
Article PubMed PubMed Central Google Scholar
I. Chiodini, D. Gatti, D. Soranna, D. Merlotti, C. Mingiano, A. Fassio, G. Adami, A. Falchetti, C. Eller-Vainicher, M. Rossini, L. Persani, A. Zambon, L. Gennari, Vitamin D status and SARS-CoV-2 infection and COVID-19 clinical outcomes. Front Public Health 9, 736665 (2021). https://doi.org/10.3389/fpubh.2021.736665
Article PubMed PubMed Central Google Scholar
G.K. Schwalfenberg, A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol. Nutr. Food Res. 55(1), 96–108 (2011). https://doi.org/10.1002/mnfr.201000174
Article CAS PubMed Google Scholar
A.G. Telcian, M.T. Zdrenghea, M.R. Edwards, V. Laza-Stanca, P. Mallia, S.L. Johnston, L.A. Stanciu, Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro. Antivir. Res. 137, 93–101 (2017). https://doi.org/10.1016/j.antiviral.2016.11.004
Article CAS PubMed Google Scholar
R.A. Brockman-Schneider, R.J. Pickles, J.E. Gern, Effects of vitamin D on airway epithelial cell morphology and rhinovirus replication. PLoS ONE 9(1), e86755 (2014). https://doi.org/10.1371/journal.pone.0086755
Article CAS PubMed PubMed Central Google Scholar
M.V. Blagosklonny, From causes of aging to death from COVID-19. Aging 12(11), 10004–10021 (2020). https://doi.org/10.18632/aging.103493. Jun 12
Article PubMed PubMed Central Google Scholar
F.M. Panfili, M. Roversi, P. D’Argenio, P. Rossi, M. Cappa, D. Fintini, Possible role of vitamin D in COVID-19 infection in pediatric population. J. Endocrinol. Investig. 15, 1–9 (2020). https://doi.org/10.1007/s40618-020-01327-0
S. Tripathi, A. Verma, E.J. Kim, M.R. White, K.L. Hartshorn, LL-37 modulates human neutrophil responses to influenza A virus. J. Leukoc. Biol. 96(5), 931–938 (2014). https://doi.org/10.1189/jlb.4A1113-604RR
留言 (0)